Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer

10.1186/bcr2817

Saved in:
Bibliographic Details
Main Authors: Li, Y., Wedrén, S., Li, G., Charn, T.H., Desai, K.V., Bonnard, C., Czene, K., Humphreys, K., Darabi, H., Einarsdóttir, K., Heikkinen, T., Aittomäki, K., Blomqvist, C., Chia, K.S., Nevanlinna, H., Hall, P., Liu, E.T., Liu, J.
Other Authors: EPIDEMIOLOGY & PUBLIC HEALTH
Format: Article
Published: 2014
Online Access:http://scholarbank.nus.edu.sg/handle/10635/109363
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-109363
record_format dspace
spelling sg-nus-scholar.10635-1093632023-09-22T07:38:27Z Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer Li, Y. Li, Y. Wedrén, S. Li, G. Charn, T.H. Desai, K.V. Bonnard, C. Czene, K. Humphreys, K. Darabi, H. Einarsdóttir, K. Heikkinen, T. Aittomäki, K. Blomqvist, C. Chia, K.S. Nevanlinna, H. Hall, P. Liu, E.T. Liu, J. EPIDEMIOLOGY & PUBLIC HEALTH 10.1186/bcr2817 Breast Cancer Research 13 1 - BCRRC 2014-11-26T07:44:56Z 2014-11-26T07:44:56Z 2011-01-26 Article Li, Y., Li, Y., Wedrén, S., Li, G., Charn, T.H., Desai, K.V., Bonnard, C., Czene, K., Humphreys, K., Darabi, H., Einarsdóttir, K., Heikkinen, T., Aittomäki, K., Blomqvist, C., Chia, K.S., Nevanlinna, H., Hall, P., Liu, E.T., Liu, J. (2011-01-26). Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer. Breast Cancer Research 13 (1) : -. ScholarBank@NUS Repository. https://doi.org/10.1186/bcr2817 14655411 http://scholarbank.nus.edu.sg/handle/10635/109363 000290278400010 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
description 10.1186/bcr2817
author2 EPIDEMIOLOGY & PUBLIC HEALTH
author_facet EPIDEMIOLOGY & PUBLIC HEALTH
Li, Y.
Li, Y.
Wedrén, S.
Li, G.
Charn, T.H.
Desai, K.V.
Bonnard, C.
Czene, K.
Humphreys, K.
Darabi, H.
Einarsdóttir, K.
Heikkinen, T.
Aittomäki, K.
Blomqvist, C.
Chia, K.S.
Nevanlinna, H.
Hall, P.
Liu, E.T.
Liu, J.
format Article
author Li, Y.
Li, Y.
Wedrén, S.
Li, G.
Charn, T.H.
Desai, K.V.
Bonnard, C.
Czene, K.
Humphreys, K.
Darabi, H.
Einarsdóttir, K.
Heikkinen, T.
Aittomäki, K.
Blomqvist, C.
Chia, K.S.
Nevanlinna, H.
Hall, P.
Liu, E.T.
Liu, J.
spellingShingle Li, Y.
Li, Y.
Wedrén, S.
Li, G.
Charn, T.H.
Desai, K.V.
Bonnard, C.
Czene, K.
Humphreys, K.
Darabi, H.
Einarsdóttir, K.
Heikkinen, T.
Aittomäki, K.
Blomqvist, C.
Chia, K.S.
Nevanlinna, H.
Hall, P.
Liu, E.T.
Liu, J.
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
author_sort Li, Y.
title Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
title_short Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
title_full Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
title_fullStr Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
title_full_unstemmed Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
title_sort genetic variation of esr1 and its co-activator ppargc1b is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/109363
_version_ 1781788686368636928